Axellis announces 'global expansion' with three acquisitions
19 March 2008
Axellis Ltd, a UK and US based medical technology company, has
announced three acquisitions, which it says are part of a strategy to
become a leading, global provider of specialist hardware and software
solutions to optimise treatments in oncology and cardiology.
The three companies taken over are:
- Innocure LLC, a US-based specialist developer of oncology
software tools and the manufacture of a new, advanced design of
compensating filters used in conjunction with linear accelerators
for the delivery of intensity modulated radiation therapy.
- Bluescope Medical Technologies Ltd, a developer of non-invasive
advanced cardio-pulmonary acoustic monitoring systems used to
measure cardiac and respiratory sounds, in addition to the
measurement and assessment of the electrical information generated
by the heart.
- Mailling Wright Products Ltd uses digital technology to capture
patient data, perform analysis in the remote design and off-site
manufacture of patient-specific immobilisation devices and
appliances for use in radiotherapy.
The company says that the acquisitions will enable it to access the
buoyant US healthcare market which launches the development of its
ambitious business plan.
Commenting on the acquisitions and the growth potential of Axellis,
Trevor Stanley, CEO said: “In making these acquisitions, Axellis has
quickly and clearly established itself as an emerging leader in the
provision of advanced software tools to support the oncology and
cardiology sectors, as well as adding an exceptional team of
"Not only do these businesses each have significant growth potential
in their own right, but they offer tremendous synergies to rapidly grow
our healthcare business through the integration of the suite of
proprietary software tools, patented technologies and derived medical
products now available from Axellis. These systems will become the
cornerstones of Axellis’ patient-centred vision”.